I-123 MIBG IMAGING OF METASTATIC CARCINOID-TUMOR FROM THE RECTUM

被引：9

作者：

WATANABE, N ^{[1
]}

SETO, H ^{[1
]}

ISHIKI, M ^{[1
]}

SHIMIZU, M ^{[1
]}

KAGEYAMA, M ^{[1
]}

WU, YW ^{[1
]}

NAGAYOSHI, T ^{[1
]}

KAMISAKI, Y ^{[1
]}

KAKISHITA, M ^{[1
]}

机构：

[1] TOYAMA MED & PHARMACEUT UNIV,DEPT INTERNAL MED,TOYAMA 93001,JAPAN

来源：

CLINICAL NUCLEAR MEDICINE | 1995年 / 20卷 / 04期

关键词：

D O I：

10.1097/00003072-199504000-00014

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

I-131 MIBG, a specific radiopharmaceutical agent for scintigraphic imaging and treatment of pheochromocytoma and neuroblastoma may be useful for detection of apudomas. Scintigraphy with I-123 radiolabeled MIBG was performed in a patient with metastatic carcinoid tumor from the rectum. I-123 MIBG scintigraphic findings showed multiple areas of abnormal tumor uptake of hepatic and bone metastases from the rectal carcinoid. Bone scintigraphy demonstrated multiple metastatic lesions. Computed tomography revealed multiple solid tumors of the liver. This report describes accumulation of I-123 MIBG in the liver and bone metastases from the rectal carcinoid. Radioiodine MIBG scintigraphy may be useful for detecting metastatic lesions, for evaluating postoperative recurrence, and also for the treatment of the carcinoid tumor.

引用

页码：357 / 360

页数：4